Emergent Health Corp (EMGE)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Mar 6, 2026, 9:30 AM EST
Emergent Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2021 | FY 2020 | FY 2013 | FY 2012 | FY 2011 | 2010 - 2007 |
|---|---|---|---|---|---|---|
Period Ending | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | 2010 - 2007 |
| Revenue | 0.12 | 0.17 | 0.99 | 1.37 | 0.71 | Upgrade
|
| Revenue Growth (YoY) | -28.48% | -83.11% | -27.52% | 93.19% | 194.95% | Upgrade
|
| Cost of Revenue | 0.04 | 0.05 | 0.32 | 0.56 | 0.46 | Upgrade
|
| Gross Profit | 0.08 | 0.12 | 0.67 | 0.8 | 0.25 | Upgrade
|
| Selling, General & Admin | 0.26 | 0.18 | 0.48 | 0.58 | - | Upgrade
|
| Research & Development | 0 | 0 | - | - | - | Upgrade
|
| Amortization of Goodwill & Intangibles | 0.02 | 0.02 | - | - | - | Upgrade
|
| Operating Expenses | 0.28 | 0.2 | 0.48 | 0.58 | - | Upgrade
|
| Operating Income | -0.2 | -0.08 | 0.19 | 0.23 | 0.25 | Upgrade
|
| Interest Expense | -0.09 | - | - | -0.02 | - | Upgrade
|
| Interest & Investment Income | - | - | 0 | 0 | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | -0 | - | - | - | Upgrade
|
| Pretax Income | -0.29 | -0.08 | 0.19 | 0.21 | 0.25 | Upgrade
|
| Income Tax Expense | - | - | 0.07 | 0.08 | - | Upgrade
|
| Earnings From Continuing Operations | -0.29 | -0.08 | 0.12 | 0.13 | 0.25 | Upgrade
|
| Minority Interest in Earnings | 0 | 0 | - | - | - | Upgrade
|
| Net Income | -0.29 | -0.08 | 0.12 | 0.13 | 0.25 | Upgrade
|
| Net Income to Common | -0.29 | -0.08 | 0.12 | 0.13 | 0.25 | Upgrade
|
| Net Income Growth | - | - | -8.06% | -48.06% | 424.81% | Upgrade
|
| Shares Outstanding (Basic) | 58 | 58 | 25 | 24 | 23 | Upgrade
|
| Shares Outstanding (Diluted) | 83 | 80 | 25 | 25 | 23 | Upgrade
|
| Shares Change (YoY) | 3.97% | 222.30% | - | 7.83% | 4.37% | Upgrade
|
| EPS (Basic) | -0.00 | -0.00 | 0.00 | 0.01 | 0.01 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.00 | 0.00 | 0.01 | 0.01 | Upgrade
|
| EPS Growth | - | - | -7.92% | -51.90% | 402.92% | Upgrade
|
| Gross Margin | 66.47% | 72.62% | 67.59% | 58.74% | 35.31% | Upgrade
|
| Operating Margin | -166.91% | -45.45% | 19.11% | 16.51% | 35.31% | Upgrade
|
| Profit Margin | -241.51% | -47.33% | 12.23% | 9.64% | 35.85% | Upgrade
|
| EBITDA | -0.18 | -0.06 | 0.19 | 0.23 | - | Upgrade
|
| EBITDA Margin | -150.18% | -33.48% | 19.15% | 16.53% | - | Upgrade
|
| D&A For EBITDA | 0.02 | 0.02 | 0 | 0 | - | Upgrade
|
| EBIT | -0.2 | -0.08 | 0.19 | 0.23 | 0.25 | Upgrade
|
| EBIT Margin | -166.91% | -45.45% | 19.11% | 16.51% | 35.31% | Upgrade
|
| Effective Tax Rate | - | - | 36.64% | 37.80% | - | Upgrade
|
| Revenue as Reported | - | - | 0.99 | 1.37 | 0.71 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.